aibioJyong Biotech files late-filing notice for its 2025 annual report on Form 20-F
Tickers MENS
The company says it needs more time to finalize its audited financial statements and expects to file within 15 calendar days of the due date.
Key facts
- Company
- Jyong Biotech Ltd. (NASDAQ: MENS)
- News type
- Distress
- Primary source
- Jyong Biotech Ltd. NT 20-F (2026-04-29)
Jyong Biotech Ltd. (Nasdaq: MENS) filed a Form NT 20-F on April 29, 2026, a notice that its annual report on Form 20-F for the fiscal year ended December 31, 2025 will be late.
The company said it is unable, without unreasonable effort or expense, to file within the prescribed period because of the additional time required to finalize its audited financial statements and other disclosures. It anticipates filing the Form 20-F on or before the 15th calendar day following the prescribed due date.
In the notice, the company answered yes to whether all other periodic reports required during the preceding 12 months have been filed. It answered no to whether it anticipates any significant change in results of operations from the corresponding period for the last fiscal year.
The forward-looking statements section lists, as a risk, changes to anticipated financial results once the independent registered public accounting firm completes its audit. The company lists its principal executive office in New Taipei City, Taiwan.